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Abstract
Background: Approximately 20-40% of outpatients with diabetes experience elevated levels of emotional distress,
varying from disease-specific distress to general symptoms of anxiety and depression. The patient’s emotional well-
being is related to other unfavorable outcomes, like reduced quality of life, sub-optimal self-care, impaired glycemic
control, higher risk of complications, and increased mortality rates. The purpose of this study is to test the
effectiveness of a new diabetes-specific, mindfulness-based psychological intervention. First, with regard to
reducing emotional distress; second, with respect to improving quality of life, dispositional mindfulness, and self-
esteem of patients with diabetes; third, with regard to self-care and clinical outcomes; finally, a potential effect
modification by clinical and personality characteristics will be explored.
Methods/Design: The Diabetes and Mindfulness study (DiaMind) is a randomized controlled trial. Patients with
diabetes with low levels of emotional well-being will be recruited from outpatient diabetes clinics. Eligible patients
will be randomized to an intervention group or a wait-list control group. The intervention group will receive the
mindfulness program immediately, while the control group will receive the program eight months later. The
primary outcome is emotional distress (anxiety, stress, depressive symptoms), for which data will be collected at
baseline, four weeks, post intervention, and after six months follow-up. In addition, self-report data will be collected
on quality of life, dispositional mindfulness, self-esteem, self-care, and personality, while complications and glycemic
control will be assessed from medical files and blood pressure will be measured. Group differences will be
analyzed with repeated measures analysis of covariance.
The study is supported by grants from the Dutch Diabetes Research Foundation and Tilburg University and has
been approved by a medical ethics committee.
Discussion: It is hypothesized that emotional well-being, quality of life, dispositional mindfulness, self-esteem, self-
care, and blood pressure will improve significantly more in the mindfulness group compared to the control group.
Results of this study can contribute to a better care for patients with diabetes with lowered levels of emotional
well-being. It is expected that the first results will become available in 2012.
Trial registration: Dutch Trial Register NTR2145.
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It has been estimated that worldwide, approximately
285.000.000 persons have diabetes mellitus (DM) and
this number is expected to rise to 439.000.000 by 2030
[1]. This sharp increase in prevalence is partly due to
the ageing of the population and the increase in the
number of people having overweight and who are physi-
cal inactive [2]. DM is a chronic disease characterized
by high levels of blood glucose resulting from a deficit
in the secretion of the hormone insulin (absolute insulin
deficiency: Type 1 DM), or insufficient insulin action
(insulin resistance) and/or a failure of the beta-cells to
produce enough insulin, i.e. beta-cell dysfunction (Type
2 DM) [3]. Type 2 DM is the most frequent form, pre-
valent in approximately 90% of the cases [4]. For all
patients with diabetes, appropriate glycemic control by
means of adequate self-management is required in order
to prevent or delay the development of diabetes compli-
cations: macrovascular complications (e.g. coronary
artery disease) and microvascular complications (i.e.
nephropathy, retinopathy, and neuropathy). This self-
management consists for example of a healthy diet, phy-
sical exercise, frequent assessment of the blood glucose
levels, and (in many cases) the use of medication to con-
trol the blood glucose (an oral hypoglycemic agent and/
or insulin)[3].
A considerable proportion of the patients with dia-
betes (20-40%) experience emotional problems, which
vary from disease-specific worries (such as fear of hypo’s
or worries about complications) to more general symp-
toms of distress, anxiety and depression [5-7]. These
problems are not only unpleasant for the persons
experiencing them, but studies show also that co-morbid
emotional distress in patients with DM is associated
with reduced quality of life [8], poor self-care behaviors
[9], more negative appraisals of insulin therapy [10],
reduced glycemic control [9]a n ds u b s e q u e n ta d v e r s e
cardiovascular outcomes, and even mortality [8,11].
Despite the fact that emotional distress is so common
in patients with diabetes, the attention for emotional
problems in both practice and research is still limited.
In practice, the recognition rates of emotional problems
by clinicians are low and so are treatment rates [12].
Similarly, in the field of diabetes research, studies that
test psychological interventions to improve the emo-
tional well-being in patients are scarce. In addition,
those studies that have been conducted often have
important limitations, such as lack of controlled designs
and small sample sizes [13]. However, it is true that the
attention for emotional problems in DM patients is
increasing since the last decade. In practice, screening
for emotional problems is recommended in the latest
versions of the standards of care of the International
Diabetes Federation [14] and the American Diabetes
Association [15]. In addition, in research, there are
more and more studies examining the effectiveness of
psychological interventions on clinical depression. Anxi-
ety symptoms and diabetes-specific emotional distress
have received, however, much less attention in diabetes
research.
The results of well-designed studies that have been
conducted to test psychological interventions in diabetes
patients with emotional problems show that cognitive
behavioral therapy is an effective treatment for major
depression in diabetes patients [16] and a potentially
effective treatment in reducing symptoms of anxiety,
perceived stress, and diabetes-specific emotional distress
[17,18]. Another promising psychological intervention
that may help to reduce symptoms of depression, anxi-
ety, and diabetes-specific emotional distress is based on
the cultivation of mindfulness. Mindfulness can be
defined as the self-regulation of one’s attention focusing
on direct experience, while adopting a curious, open,
and accepting attitude towards these experiences, espe-
cially one’s psychological processes, such as thoughts
and feelings [19]. Mindfulness-based interventions can
be considered promising as positive effects of mindful-
ness programs on emotional well-being and quality of
life have been reported in diverse patients groups, like
chronic pain patients and patients with cancer [20-22].
In addition, research has shown that the program is
beneficial for patients with recurrent depression. In
these patients, the intervention appeared to be superior
to traditional cognitive behavioral therapy in the preven-
tion of relapse of depression [23]. While in a recent
meta-analysis, mindfulness-based interventions have
been found to have medium to large effects regarding
the reduction of symptoms of anxiety and depression
[24], only two studies have focused on the effects of a
mindfulness program on patients with diabetes. These
studies showed that the interventions resulted in
improved emotional well-being (Cohen’s d =0 . 8 6f o r
depressive symptoms and 0.43 for anxiety) [25],
improved self-care behaviors (Cohen’s d = 0.68)[26] and
decreased HbA1c values (Cohen’s d =0 . 4 6 )[ 2 5 ]
(Cohen’s d = 0.35)[26]. However, only one of the two
studies was a randomized controlled trial, but this study
did not include emotional well-being as an outcome
measure [26]. Therefore, there is a clear need for rando-
mized controlled studies in this area, examining the
potential benefits of mindfulness interventions on emo-
tional well-being in patients with DM.
In addition to the potential contribution of mindful-
ness to emotional well-being, mindfulness may also have
a beneficial influence on self-management in DM
patients. First, because mindfulness interventions
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associated with better self-care behavior, mindfulness is
expected to enhance self-care behavior as well. Second,
mindfulness improves one’s ability to behave oneself
constructively in harmony with his/her values, even dur-
ing the experience of difficult thoughts and emotions
[27]. Finally, because considerable focus is placed on
bodily sensations during mindfulness interventions,
mindfulness leads people to become more in touch with
their body and its signals and needs [28], which is
expected to lead to better self-care.
A positive effect of a mindfulness intervention may
also be expected on blood pressure. It is known that
episodic or chronic emotional distress can increase
blood pressure [29]. This is unfavorable for patients
with diabetes, as the prevalence of high blood pressure
in people with diabetes is approximately twice as high
compared to the general population [30] and both dia-
betes and high blood pressure are important risk factors
for cardiovascular disease [30]. To date, only two studies
have examined the influence of mindfulness on blood
pressure, finding a reduction in mean arterial pressure
in DM patients [25] and a reduction in resting systolic
blood pressure in normotensive students [31].
If the mindfulness intervention appears to be effective
in reducing emotional distress in DM patients, it is use-
ful to know which patients will most likely benefit from
the intervention. However, research into differences in
effectiveness of the intervention between groups of
patients with different characteristics (e.g. differences in
personality and demographic and medical characteris-
tics) is scarce.
Objectives and hypotheses
Because of the paucity of studies on the effectiveness of
psychological interventions for emotional problems in
DM patients, especially regarding mindfulness based
interventions, the purpose of this study is to test the
effectiveness of a mindfulness-based psychological inter-
vention. The primary outcome is emotional distress
(symptoms of depression, anxiety, diabetes-specific
stress, and general perceived stress). Secondary out-
comes are quality of life, (diabetes-specific) mindfulness,
and self-esteem, and our tertiary outcomes are self-
management, glycemic control, and blood pressure.
Finally, we will examine which patient characteristics
(like the extent of complications and personality) predict
which patients most likely benefit from the intervention.
With regard to our first outcome measure, we
hypothesize that after an eight-week mindfulness-based
training DM patients will experience significant greater
reductions in emotional distress (diabetes-specific stress,
anxiety, and depressive symptoms) compared to a wait-
list control group. Concerning our secondary outcome
measures, we hypothesize that the intervention will lead
to greater improvements in psychological quality of life,
dispositional (diabetes-specific) mindfulness, and self-
esteem compared to a wait-list control group. In addi-
tion, we expect, consistent with two other studies
[32,33], that changes in dispositional mindfulness will
mediate the hypothesized effects of the intervention on
above mentioned outcomes. Regarding our tertiary,
more clinical, outcome measures, we hypothesize that
the intervention will lead to better diabetes self-care,
lower HbA1c, and lower BP in people with elevated BP.
Finally, we are interested in personality and clinical fac-
tors that could possibly act as effect modifiers. We do
not have clear expectations about the direction of the
possible influence of these characteristics, being compli-
cations (yes/no), diabetes type (DM1 versus DM2), co-
morbidity (yes/no), and personality.
Methods/Design
Study design
The Diabetes and Mindfulness (DiaMind) study will be
conducted as a randomized controlled trial (RCT).
D u t c hs p e a k i n gp a t i e n t sw i t hD Mw i t hl o wl e v e l so f
emotional well-being recruited from outpatient diabetes
clinics will be randomly allocated to the intervention
group or the wait-list (usual care) control group. The
intervention group will receive the mindfulness program
immediately, while the control group will receive the
program eight months later (six months after the train-
ing of the intervention group).
Eligibility
We will include adult men and women (aged 18 -
80 years) who were diagnosed with diabetes (type 1 or 2)
and have poor emotional well-being as evidenced by a
score of < 13 on the WHO-5 well-being Index [34].
Patients will be excluded when they have a recent history
of severe psychopathology (i.e., psychosis, risk of suicide
attempts); or alcohol/drugs abuse; have a severe physical
co-morbidity (i.e., severe forms of cancer or heart failure);
when they have insufficient reading and comprehension
skills of the Dutch language; when they are already in an
(extensive) psychological treatment which started within a
period of 6 weeks before the start of the training; and
when they already have meditation experience (with
Vipassana, Zen, or Dzogchen).
Recruitment and screening process and enrolment
The recruitment of patients will take place in outpatient
diabetes clinics. At present, internists of the outpatient
clinic of the Maxima Medical Center (Veldhoven and
Eindhoven), the Catharina Hospital (Eindhoven) and the
TweeSteden Hospital (Tilburg) have agreed to partici-
pate. Depending on the preferences of the diabetes
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be conducted by the internists, diabetes nurses or by a
researcher of our team. The screening tool will be the
WHO-5 well-being Index [34]. This short (5-item)
screening instrument, which assesses emotional well-
being, is validated in the general population, but also in
different patient samples, including patients with type 1
diabetes [35] and is recommended for use by the Inter-
national Diabetes Federation (IDF) [14]. If patients have
a low score on this scale (<13) they will receive an infor-
mation letter about the training and study. One week
later these patients will be telephoned and asked
whether they are interested to participate in the project.
Eligible patients who are interested to participate will
be invited for a short interview. This interview will take
place in the hospital or, if logistically difficult for the
patient, at their home. During this interview the in- and
exclusion criteria will be checked once again, and expec-
tations of the patient about the training will be checked
and if necessary adjusted. Eligible patients will receive a
written informed consent form during the interview that
has to be signed and returned before the start of the
training. Furthermore, at the end of the interview the
blood pressure of the patients will be measured. If blood
pressure is elevated (≥140/90 mmHg) the patient will be
attached to an ambulatory blood pressure device which
will measure blood pressure the following 24 hours.
One day later the device will be brought back to the
hospital by the patient or be picked up at the patient’s
home by a researcher.
Randomization
After the inclusion of every 16 to 20 patients the partici-
pants will be randomized into two groups: the interven-
tion group and the control group. The randomization
will be done as follows. After the interview and upon
receipt of a signed informed consent form, the patient
will be assigned to a participant number. Subsequently
the participant will receive the baseline questionnaire by
mail or email. When the first author receives the baseline
assessment, she passes on the corresponding participant
number to the second author who has no further involve-
ment in the practical recruitment, enrolment, and assess-
ment of the patients. The second author will refer to the
computer generated (through PASW Statisitics 17) ran-
dom list (uneditable and concealed for others) prepared
by a statistician with no involvement in the trial. The sec-
ond author will inform the first author about the alloca-
tion by email and will archive the allocations in a secured
document on his computer. The first author will docu-
ment the allocation in the general inclusion database,
which will be checked by the second author. The first
author will inform the patients both by telephone and let-
ter about their allocation. The above described procedure
will eliminate experimenter bias in group assignment.
The computer program the statistician will use utilizes a
random number generator and will be programmed to
insure equal numbers of subjects in each arm of the
study within a block of 4 participants.
Masking
The nature of this psychological intervention does not
allow “masking” or blinding of patients, and trainers.
However, the statistician who will be involved in data
analyses will be blinded for treatment allocation. All the
questionnaires and homework forms will only be
marked with a participant number, which is unknown
to the trainer and researcher.
Intervention
Training
The protocolised mindfulness training is based on the
Mindfulness-Based Stress Reduction and Mindfulness-
Based Cognitive Therapy programs as described in
Kabat-Zinn [28] and Segal et al. [36], consisting of eight
weekly two-hour sessions. A few modifications have been
made to the original protocol and the workbook in order
to make the intervention suitable for patients with dia-
betes. For example, the trainers explain the potential
associations between emotional problems and diabetes
management and diabetes outcomes (e.g., the associa-
tions between emotional stress and eating behaviors will
be discussed). Instead of the silent day that is part of the
original program, a two-hour booster session has been
added three months after the end of the intervention. At
each session the participants will receive homework
assignments that take about 30 minutes 5 days per week.
All the sessions will be supervised by certified psycholo-
gists who have at least four years practical experience
with mindfulness, and also completed a mindfulness
instructors training of eight days in The Netherlands.
The standard format of the sessions is as follows: the ses-
sion starts with an exercise, which is followed by a dis-
cussion about the exercise and the homework exercises
of the preceding week. Subsequently, a discussion about
the theme of the session takes place, followed by the
administration and discussion of one or two other mind-
fulness exercises. Finally, the homework assignments of
the following week are discussed. All sessions end with a
short meditation and/or a relevant poem or story.
Session 1 The first session of the course will consist of:
1) an invitation to all participants to introduce them-
selves sequentially, 2) a brief overview of the coming
eight weeks, 3) a discussion about the relationship
between diabetes, diabetes management, diabetes out-
comes and emotional distress. After this, participants
will be invited to slowly and mindfully eat a raisin with
all their senses (the raisin exercise), which will be
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ple live their lives in a unmindful way, often do not pay
much attention to what they are doing. Subsequently,
the participants will be led through a body scan exercise
of thirty-five minutes, during which the participants are
encouraged to focus on the physical sensations in differ-
ent body parts and to bring their attention back to that
focus when they get distracted from it by thoughts or
other momentary phenomena. At the end of the first
session the participants will receive a CD containing
several exercises and will be asked to practice the body-
scan on five occasions in the following week. In addi-
tion, they will be advised to perform one daily activity
(e.g. to wash the dishes, to brush their teeth) in a mind-
ful way and to eat one meal per day mindfully.
Session 2 At the beginning of the second session the
participants will be guided again through the body scan,
after which they will be invited to express and share
their experiences with the mindfulness exercises and the
homework of the preceding week. Subsequently there
will be a discussion about coping with obstacles to
doing the exercises (e.g., irritation, wandering mind) and
attitudes that support the cultivation of mindfulness
(e.g., not judging, letting go). After that, participants will
be led through an exercise ‘thoughts and feelings’, which
explains a basic component of cognitive behavioral ther-
apy: our emotions are not caused by events but by our
perception of events. Subsequently, the participants will
practice ‘sitting meditation’, with breathing as the pri-
mary object of attention. Home practice for the follow-
ing week will include awareness of pleasant events, a
new routine daily activity, the bodyscan, and brief sitting
meditation.
Session 3 The third session will start with a short ‘See-
ing and/or hearing exercise’, in which participants are
instructed to exercise non-judgmental seeing or hearing
for a couple of minutes. This exercise will be followed
by a sitting meditation with focus on breathing and bod-
ily sensations. After the homework discussion, there will
be a talk by the trainer about attention to breathing, fol-
lowed by the practice and discussion of the ‘3-minute
breathing space’. This meditation has three phases:
attention to the experiences in the moment, attention to
the breathing, attention to the body. Subsequently, an
exercise in mindful body movements will be introduced
and discussed. Exercises to be practiced during the fol-
lowing week will include sitting meditation, bodyscan or
body movement exercises, 3-minute breathing space,
new mindful daily activity, and awareness of unpleasant
events.
Session 4 The fourth sessions will start with a sitting
meditation with attention to the breathing, the body,
sounds, and thoughts (so called ‘sitting meditation with
four focuses’). Subsequently, there will be a discussion
about the stress response and common reactions of
individuals to difficult situations, and alternative atti-
tudes and reactions will be discussed. Then a Dutch
documentary about MBSR (entitled ‘Aandachttraining’)
will be shown to the participants. At the end of the ses-
sion an exercise in mindful walking will be introduced
and practiced. The homework assignments for this fourth
session will consist of practicing sitting meditation,
the bodyscan or mindful body movements, 3-minute
breathing space (also during unpleasant events), to fill
in the questionnaire ‘automatic thoughts’ (optional),
and to read an inspiring book about mindfulness
(optional).
Session 5 At the beginning of the fifth session the parti-
cipants will be guided through the sitting meditation
with four focuses (see Session 4). A poem will be read
and the psychologist will discuss the theme of the fifth
session: ‘Acknowledging and accepting the reality of the
present situation as it is.’ Subsequently, the second ser-
ies of mindful body movements will be introduced. The
recommended home work will consist of sitting medita-
tion, 3-minute breathing space, 3-minute breathing
space during unpleasant events, and a new daily activity
performed mindfully.
Session 6 The sixth session will begin with the 3-minute
breathing space. The homework assignments will be dis-
cussed mindfully in pairs. An exercise called ‘mood,
thoughts, and different view points’ will be discussed
plenary, as well as the theme of the sixth session: ‘The
content of our thoughts is (often) not factual’.S u b -
sequently, the participants will be guided through four
linked up meditation exercises, with a total duration of
one hour. For the following week participants will be
encouraged to choose a combination of meditations that
fits their needs and personal preferences. In addition,
the home practice includes the 3-minute breathing
space (also during unpleasant events), a new mindful
daily activity, and having a mindful conversation while
paying attention to one’s automatic patterns (optional).
Session 7 The seventh sessions will start with the medi-
tation exercise with four focuses and open awareness (to
whatever enters consciousness from moment to
moment). The theme of the session, ‘What is the best
way to care for oneself’, will be discussed, followed by
an exercise during which participants explore daily
activities that are pleasant versus unpleasant and learn
to plan sufficient pleasant activities. The 3-minute
breathing space is performed, followed by a loving-
kindness meditation during which one practices kind-
ness towards oneself and others. The home practice
includes a meditation combination of one’sc h o i c e ,
3-minute breathing space (also during unpleasant events),
a new daily activity performed mindfully, and filling in a
form including warning signals for emotional distress.
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theme of the last session will be discussed: ‘Using what
you have learned’. Subsequently the psychologist will
guide the participants through a 3-minute breathing
space and will read a story called ‘Five chapters’,w h i c h
is about the steps one can take to overcome our pitfalls
in the practice of mindfulness. Finally, the whole train-
ing will be evaluated with the participants. For example
the following questions will be asked: did the training
meet their expectations, do participants have a sense of
‘personal growth’, do they feel that they have expanded
their coping skills and do they want to continue practi-
cing mindfulness. In addition, resources for continued
practice will be given (e.g. titles of books and addresses
of local meditation centers).
Evaluation
After completing the training the patients will be invited
for a short interview, in which the patient’s perceptions
regarding the quality of the intervention will be evalu-
ated and the procedure with the ambulant blood pres-
sure measurement will be repeated.
Data collection
Table 1 shows the assessment instruments and data col-
lection time points. Assessments will take place before
the start of the intervention, at 4 weeks, at 8 weeks
(= post intervention), at 12 weeks and at 34 weeks
(6 months post intervention). The control group will
receive another four measures, namely at 38 weeks
(4 weeks after start of control group intervention), at
42 weeks (post control group intervention), at 46 weeks,
and at 62 weeks (6 months post control group interven-
tion). Process variables (e.g., attendance, adherence, and
drop-out) will be collected continuously. The patients
who have access to the internet and email will receive
the questionnaire via the internet. If this is not the case,
they will receive a paper version of the questionnaire
along with a stamped addressed envelope.
Outcome parameters
1. Primary outcome measures
Stress, anxiety and depressive symptoms We will
include the Hospital Anxiety and Depression Scale
(HADS) to measure symptoms of anxiety (HADS-A:
e.g., “Worrying thoughts go through my mind”)a n d
depression (HADS-D: e.g., “I feel as I am slowed down”)
in DM patients [37]. The self-report scale consists of 14
items, answered on a 4-point Likert scale, with the
HADS-A and HADS-D both comprising 7 items (0-3).
The score range for the anxiety and the depressive
symptoms subscales is 0 to 21. The HADS has been
validated in the general population and in somatic and
psychiatric patients [38,39]. It has been shown to be a
Table 1 Measurements and time points
Concept Questionnaire Measurement time points
T1 T2 T3 T4 T5 T6 T7 T8 T9
Perceived stress PSS (14)* xxx xxx x
Anxiety and depressive symptoms HADS (14) xxx xxx x
Mood POMS (32) xxx xxx x
Diabetes related problems PAID (20) xxx xxx x
Quality of life SF12 (12)+3 items WHOQOL xxxxx
Self-care behavior ADSCI (11) xxxxx
Extraversion EPQ-E (12) x
Type D Personality DS14 (14) xxxxx
Mindfulness FFMQ(31) xxxxx
Diabetes related mindfulness AADQ (11) xxxxx
Self-esteem RSES (10) xxxxx
Patient’s background (demographics, clinical, psychological) - (21) x
Clinical measurements Measurement
Glycemic control (from hospital database) hbA1c xx x xx
Blood pressure Amb.24 h BP xx
T1 - baseline; T2 - after 4 weeks of intervention; T3 - after 8 weeks (post intervention); T4 - after 12 weeks (4 weeks post intervention); T5 - after 8 months
(6 months post intervention = start training for control group). T6 thru T9 only for control group: repetition of T2 thru T5. PSS - Perceived Stress Scale; HADS -
Hospital Anxiety and Depression Scale; POMS - Profile of Mood States; PAID - Problem Areas in Diabetes Survey; SF-12 - Short Form Health Survey; 3 items
WHOQOL-bref
9; ADSCI - Amsterdam Diabetes Self Care Inventory; EPQ-E - Eysenck Personality Questionnaire subscale Extraversion; DS14 - Type D personality
scale; FFMQ - Five Factor Mindfulness Questionnaire; AADQ - Acceptation and Action Diabetes Questionnaire; RSES - Rosenberg Self-esteem Scale. HbA1c =
hemoglobin A1c (the amount of glycated hemoglobin in blood). Amb. 24 h BP = Ambulatory 24 hour Blood Pressure monitoring.
*= number of items in questionnaire. Total number of items = 205.
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from 0.67 to 0.93 for the two subscales [37-39].
The Dutch version of the Perceived Stress Scale (PSS)
will be included to measure general perceived stress (the
degree to which situations in one’s life are appraised as
stressful) (e.g. “In the last month, how often have you
felt nervous and stressed?”). It has been shown to be a
reliable measure with Cronbach’s a ranging from 0.84
to 0.86 [40]. The present version consists of 10 items
which are answered on a five-point Likert scale, ranging
from ‘never’ to ‘very often’ (0-4) [41].
The short Dutch version of the Profile of Mood States
(POMS) [42] will be used to assess transient, fluctuating
mood states. The scale consists of 32 adjectives about
positive and negative mood states which have to be
rated on a five-point Likert scale ( 0=n o ta ta l l ,4=
very much) based on how well each item describes one’s
mood during the last couple of weeks. For the interpre-
tation of the results the items are divided into five sub-
scales: Tension-anxiety (6 items); Depression-dejection
(8 items); Anger-hostility (7 items); Vigor-activity
(5 items); and Fatigue-inertia (6 items). The scale has
sufficient consistency reliability and construct validity,
with Cronbach’s a’s of the five subscales varying
between 0.82 and 0.91 [42,43].
Diabetes specific emotional problems We will include
the Dutch version of the self-report questionnaire Pro-
blem Areas in Diabetes Survey (PAID), which consists
of 20 statements about common negative feelings
related to living with diabetes (e.g., “Feeling depressed
when you think about living with diabetes”, “feeling dis-
couraged with your diabetes regimen”) [44]. The items
are rated on a six-point Likert scale (1 = not a problem,
6 = a serious problem). PAID scores are transformed to
a 0-100 scale, to facilitate interpretation [45]. A higher
score indicates more emotional distress, with a cut-off
score of 40 indicating seriously elevated emotional dis-
tress [46]. Factor analysis revealed that the factor struc-
ture can be represented by a one factor model (PAID
total: emotional adjustment) and a four factor model
(subscales: emotional problems, treatment problems,
food problems, and lack of social support) [45]. We will
examine the results with both models. The survey has
proven to be a reliable measure, with a Cronbach’s a of
0.95 for the one factor model. For the four factor model
the Cronbach’s a’s are in range of 0.93 (emotional pro-
blems), 0.74-0.76 (treatment problems), 0.70-0.74 (food
problems), and 0.69-0.72 (lack of social support) [45]. In
addition, research in Dutch and American patients
found support for convergent and discriminative validity
of the PAID [45,47].
2. Secondary outcome measures
Quality of life We will include the Dutch version of the
Short-Form Health Survey (SF-12) to measure health
related quality of life. The self-report scale consists of
12 items that are grouped into two component sum-
mary scores: a physical (PCS) and a mental component
score (MCS). Both component scores are measured on a
scale from 0 to 100, with a high score indicating good
health related quality of life. The SF12 has proven to be
a valid and reliable measurement [48].
In addition, we will use three items of the WHOQOL-
BREF [49] to measure satisfaction with oneself and life
in general: “How much do you enjoy life?"; “To what
extent do you feel your life to be meaningful?"; “How
satisfied are you with yourself?”. The questions will be
analyzed separately at item level if Cronbach’s a will
show to be below 0.65.
Mindfulness To measure mindfulness we will include
the Dutch version of the Five Facet Mindfulness Ques-
tionnaire (FFMQ). FFMQ is based on a factor analytic
study of five independently developed mindfulness mea-
surement scales [50]. The factors we will use are: Obser-
ving, which refers to noticing or attending to internal
and external experiences, such as thoughts, sensations,
emotions, sounds, sights, and smells; Acting with aware-
ness, which includes attending to one’s activities in the
present moment; Non-judging of inner experience, which
refers to taking a non-evaluative attitude toward
thoughts and feelings; and Non-reactivity to inner
experience, which includes allowing thoughts and feel-
ings to come and go, without getting caught up in or
carried away by them [51]. The factor Describing will be
omitted, because describing one’s emotions and feelings
is not a primary focus of MBSR/MBCT and we do not
want to burden our patients unnecessarily. Each factor
consists of 7 or 8 items, which will be answered on a
five-point Likert scale (1 = never or very rarely true, 5 =
very often or always true). The four facets demonstrated
adequate to good internal consistency (alphas ranging
from 0.75 to 0.87) [50].
Changes in diabetes-specific mindfulness and accep-
tance processes will be assessed by the Acceptance and
Action Diabetes Questionnaire (AADQ) [26]. This self-
report questionnaire consists of 11-items that are
answered on a 7-point Likert scale. It measures accep-
tance of diabetes-related feelings and thoughts and the
extent to which they interfere with valued action (e.g.,
“I avoid thinking about what diabetes can do to me”)
[26]. For this measure, a Cronbach’s a of 0.94 has been
reported [26].
Self-esteem Self-esteem will be measured by the Dutch
version of the Rosenberg Self-Esteem Scale (RSES),
wherein self-esteem is defined as a person’s overall eva-
luation of his or her worthiness as a human being [52].
The questionnaire consists of 10 items answered on a
four-point Likert scale, ranging from ‘I totally disagree’
to ‘It o t a l l ya g r e e ’. A sample item is “It a k eap o s i t i v e
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global self-esteem. The Cronbach’s alpha was .86, indi-
cating a high internal consistency [52].
3. Tertiary outcome measures
Self-care behavior Self-care behavior (or self-manage-
ment) will be assessed with the Amsterdam Diabetes
Self Care Inventory (ADSCI). The questionnaire has 11
items, which will be examined separately. Each item is
divided into three or four subquestions. Higher scores
indicate higher levels of self-care. The questionnaire is
developed by colleagues of the VU University Medical
Center in Amsterdam and used in previous trials
[53,54]. The psychometric properties of the ADSCI have
not yet been published.
Glycemic control To measure glycemic control we will
consult the three-monthly standard measurements of
HbA1c of the hospital, which are documented in the
hospital’s patient database. The percentage HbA1c is a
function of the glucose concentration to which the red
blood cells are exposed and gives an indication of the
average blood glucose concentration of the preceding
six to eight weeks [3].
Blood pressure The patients’ blood pressure will be
measured by an ambulant device, called the Mobil-O-
Graph, which is based on the oscillometric method and
which has been shown to provide reliable and valid
assessments [55]. The patients, who have elevated high
blood pressure (≥ 140 mmHg systolic or 90 mmHg dia-
stolic of the mean values of 3 measurements) during the
interview, will wear the meter 24 hours following the
interview. The ambulatory measurements will occur two
times per hour. To keep the burden for the patients as
low as possible, we decided to measure the blood pres-
sure only during the daytime. The device will be
attached to the patient by the researcher who does the
interviews (JvS).
1. Additional outcome measures
Personality To measure personality dimensions we will
use the subscale Extraversion (EPQ-E) of the shortened
revised Eysenck Personality Questionnaire (EPQ-RSS)
and the DS-14 to measure Type D personality. Persons
with a Type D personality tend to experience high levels
of emotional distress, but do generally not express these
emotions. For the EPQ-E, the subscale Extraversion
reflects sociability, assertiveness, and the tendency to
experience positive emotions. The subscale consists of
12 dichotomous (yes/no) items [56]. The Committee on
Test Affairs Netherlands rates the EPQ to be a reliable
measure [57].
The 14-item Type D scale (DS14) measures both
negative affectivity (NA) (e.g. “I often feel unhappy";
7 items) and social inhibition (SI) (e.g. “Ia mac l o s e d
kind of person"; 7 items) [58]. Items are answered on a
five-point Likert scale ranging from ‘false’ to ‘true’ (0-4),
with the score range for the NA and SI subscales being
0t o2 8[ 5 8 ] .W ew i l lu s et h es t a n d a r d i z e dc u t - o f f≥ 10
on both subscales to identify Type D caseness [58,59].
The DS14 has been shown to be a valid and reliable
instrument, with Cronbach’s a of 0.88 and 0.86 and a
3-month test-retest reliability of r = 0.72 and 0.82 for
the NA and SI subscales, respectively [58]. Furthermore,
ar e c e n ts t u d ys h o w e dt h a tT y p eDp e r s o n a l i t yi sa
stable construct over an 18-month period and is not
confounded by disease severity and measures of anxiety
and depression [60,61]. Results from a study by Denollet
et al [62] suggest that particularly the interaction
between NA and SI is predictive of adverse health out-
comes, more than the single traits [62].
Demographic and clinical variables Demographic vari-
ables will be collected by means of a questionnaire,
which will be completed by the patients during the
baseline assessment. Data will be collected regarding the
participant’s age, marital status, education, and job sta-
tus. In addition, the baseline questionnaire will be used
to gather information on history of emotional problems
and use of psychotropic medication, level of meditation
experience, sleep quantity and quality, participant’s per-
ceived importance of adequate blood glucose regulation,
and amount of participant’s effort to manage their blood
glucose. Furthermore, the baseline questionnaire will be
used to assess clinical data, such as length and weight of
participants, last HbA1c, number of severe hypoglycemic
episodes and/or hospitalizations because of a diabetic
coma during the past year, existing diabetes complica-
tions, co-morbidities, and smoking and drinking beha-
vior. The clinical variables (which are available) will also
be retrieved from the hospitals’ patient information
database.
1. Additional process measures
During the intervention process data will be collected,
like drop-out, patients’ attendance of the sessions,
patients’ adherence to the home work assignments, and
trainers’ adherence to the protocol. The adherence to
the protocol will be determined each session by the trai-
ners by means of the completion of a checklist including
all components of each session. The components are
divided into important and less important, facilitating
decision making when time constraints are present.
Statistical analyses
Sample size and power calculation
The total number of patients that have to be included
and complete the study is 160, with 80 patients in each
arm, taking into account a medium effect size, a power
of 0.80, an alpha of 0.05, patient attrition, and subgroup
analyses involving two equally sized groups (e.g. yes vs.
no complications). It is expected to reach this number
of participants during the course of the study.
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Repeated measures analysis of variance ((M)ANCOVA)
will be used to test the hypotheses concerning the dif-
ferences between groups on the dependent variables
over time. In these tests age, sex, and co-morbidity will
be included as covariates, in addition to those other
potentially confounding variables that will show an at
least marginally significant (p < .10) difference between
groups. The analyses concerning the subgroup effects
will be conducted on the sample as a whole, whereby
possible moderating variables, like complications and
personality will be included in the analyses as between-
subjects factors. All analyses will be based on the inten-
tion-to-treat approach.
Ethical principles
The study protocol has been approved by the medical
ethical committee of the St. Elisabeth Hospital in Til-
burg, The Netherlands (P0948).
Discussion
T h ep r e s e n ta r t i c l ep r o v i d e sa no u t l i n eo ft h eb a c k -
ground and design of the Diabetes and Mindfulness
(DiaMind) study. This study’s objective is to test an
intervention based on mindfulness training supplemen-
ted with elements from cognitive therapy that aims to
improve emotional well-being of distressed patients with
diabetes. For this purpose, an intervention group will be
compared with a wait-list control group with treatment
as usual.
Research on psychological interventions that aim to
reduce emotional problems in DM patients is important,
as emotional problems are associated with a higher risk
of impaired quality of life [8], less optimal self-care [9],
incident complications, and mortality [8,11]. However,
to date there are few methodologically well-designed
studies on the effectiveness of psychological interven-
tions for people with diabetes and emotional complaints.
In addition, the majority of these studies have focused
on improving self-management instead of emotional
well-being. Moreover, the few randomized studies that
have examined the effectiveness of interventions in
reducing emotional problems in people with diabetes
often focused on depression. For this reason, this study
is clearly of added value in the research field of diabetes
and emotional problems, as we have taken a broader
perspective and focused on emotional distress (depres-
sion, anxiety, and general distress).
The study design has a number of important
strengths. First, the present study has more power to
generate knowledge on the effectiveness of a mindful-
ness-based intervention for DM patients with emotional
problems than former studies examining mindfulness in
DM patients. As mentioned before, only two studies
have been done on this subject, of which one lacked a
control group and one did not include emotional well-
being as an outcome [25,26]. Second, an additional
strength of this study is the inclusion of both psycholo-
gical and clinical measures, while most randomized con-
trolled trials examining mindfulness interventions
include psychological measures only. Finally, another
strong aspect of this study is the examination of factors
that potentially moderate the effectiveness of the mind-
fulness intervention, including clinical (e.g. complica-
tions) and psychological (e.g. personality) variables.
Results may facilitate more effective allocation of
patients to treatments.
The recruitment has already started in the Catharina
Hospital in Eindhoven in spring 2010 and in the Max-
ima Medical Center in autum n2 0 1 0 .A tp r e s e n t ,9 6 9
individuals have been screened for emotional problems.
Of those, 811 did not qualify: 658 had a score above 12
on the WHO-5 screening instrument, and 153 were
ineligible (no mastery of the Dutch language, psychiatric
disorder, or severe physical condition). Of the eligible
patients, 120 declined participation (no perceived need
or motivation for the training or an incompatible work-
ing schedule). At present, 42 patients are interested to
participate, of whom 16 have been enrolled so far.
The recruitment of a sufficient number of patients will
be a challenge. For instance, the mindfulness interven-
tion requires participants to commit to attending eight
two-hour group sessions and to practice exercises at
home for five days per week. For people who have busy
lives this sometimes is a challenge to comply with,
which may make them decline participation or drop out
of the study.
Concerning the benefits of the present study, the
results will provide valuable information regarding the
effectiveness of the mindfulness intervention for DM
patients in improving emotional well-being. We will also
gain insight in the pros and cons of a possible implemen-
tation of the intervention in usual medical care of DM
patients. By doing this, we aim to find ways that can con-
tribute to increased emotional well-being and quality of
life in patients with diabetes mellitus.
In conclusion, considering the prospected increase of
the prevalence of diabetes, the levels of emotional dis-
tress in this patient group, and the incompleteness of
the current literature on effective psychological interven-
tions for the distressed patients, well-designed trials on
psychological interventions are a welcome addition in
the diabetes research. In the present randomized con-
trolled trial the effectiveness of a psychological interven-
tion will be examined in which the cultivation of
mindfulness (the direction of attention to one’se x p e r i -
ences in the present moment in an open and accepting
manner) plays a central role. This intervention may be
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therapy in improving emotional well-being in DM
patients. The first results of the study will become avail-
able in 2012.
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